| top | |
| BRAINLIFE NEWSLETTER | |
Volume 3, Number 17 - 28
May 2004 |
|
|
|
|
|
Contents |
|
|
|
|
| Early Detection | |
| Etiology & Pathogenesis | |
| Overall Management | |
| Prognosis & Outcome | |
| Treatment | |
|
|
|
|
|
|
|
|
|
| Larijani B, Bastanhagh MH, Pajouhi M, Kargar Shadab F,
Vasigh A, Aghakhani S Presentation and outcome of 93 cases of craniopharyngioma Eur J Cancer Care (Engl). 2004 Mar;13(1):11-5. |
|
|
|
|
|
|
|
|
|
|
|
Tong CY, Hui AB, Yin XL, Pang JC, Zhu XL, Poon WS,
Ng HK Detection of oncogene amplifications in medulloblastomas by comparative genomic hybridization and array-based comparative genomic hybridization J Neurosurg. 2004 Feb;100(2 Suppl):187-93. |
|
|
|
|
|
|
|
|
|
|
|
Hurley DM, Ho KK MJA Practice Essentials--Endocrinology. 9: Pituitary disease in adults  Med J
Aust. 2004 Apr 19;180(8):419-25. |
|
|
Komninos J, Vlassopoulou V, Protopapa D, Korfias S,
Kontogeorgos G, Sakas DE, Thalassinos NC Tumors metastatic to the pituitary gland: case report and literature review J Clin Endocrinol
Metab. 2004 Feb;89(2):574-80. |
|
|
Winfree CJ, Mack WJ, Sisti MB Solitary cerebellar metastasis of malignant pleural mesothelioma: case report Surg Neurol. 2004 Feb;61(2):174-8; discussion 178-9. |
|
|
|
|
|
|
|
|
|
|
| Buckner JC Factors influencing survival in high-grade gliomas Semin Oncol. 2003 Dec;30(6 Suppl 19):10-4. |
|
| Keles GE, Lamborn KR, Chang SM, Prados
MD, Berger MS Volume of residual disease as a predictor of outcome in adult patients with recurrent supratentorial glioblastomas multiforme who are undergoing chemotherapy J Neurosurg. 2004 Jan;100(1):41-6. |
|
|
Maldaun MV, Suki D, Lang FF, Prabhu S, Shi W, Fuller GN,
Wildrick DM, Sawaya R Cystic glioblastoma multiforme: survival outcomes in 22 cases J Neurosurg. 2004 Jan;100(1):61-7. |
|
| Stupp R, Janzer RC, Hegi ME, Villemure
JG, Mirimanoff RO Prognostic factors for low-grade gliomas Semin Oncol. 2003 Dec;30(6 Suppl 19):23-8. |
|
|
|
|
|
|
|
|
|
|
| Bolko P, Jaskula M, Wasko R, Wolun M, Sowinski J The assessment of cabergoline efficacy and tolerability in patients with pituitary prolactinoma type Pol Arch Med Wewn. 2003 May;109(5):489-95. |
|
| Brada M, Stenning SP Radiotherapy for malignant gliomas in the elderly Semin Oncol. 2003 Dec;30(6 Suppl 19):63-7. |
|
|
Brandes AA State-of-the-art treatment of high-grade brain tumors Semin Oncol. 2003 Dec;30(6 Suppl 19):4-9. |
|
| Brandes AA, Monfardini S The treatment of elderly patients with high-grade gliomas Semin Oncol. 2003 Dec;30(6 Suppl 19):58-62. |
|
| Brown PD, Buckner JC, O'Fallon JR, Iturria NL, Brown
CA, O'Neill BP, Scheithauer BW, Dinapoli RP, Arusell RM, Abrams RA, Curran
WJ, Shaw EG; North Central Cancer Treatment Group; Mayo Clinic Adult patients with supratentorial pilocytic astrocytomas: a prospective multicenter clinical trial Int J Radiat Oncol Biol Phys. 2004 Mar 15;58(4):1153-60. |
|
|
Chang SM, Theodosopoulos P, Lamborn K, Malec M,
Rabbitt J, Page M, Prados MD Temozolomide in the treatment of recurrent malignant glioma Cancer. 2004 Feb 1;100(3):605-11. |
|
| Chinot OL Should radiotherapy be standard therapy for brain tumors in the elderly? Cons Semin Oncol. 2003 Dec;30(6 Suppl 19):68-71. |
|
| Rades D, Fehlauer F, Schild SE Treatment of atypical neurocytomas Cancer. 2004 Feb 15;100(4):814-7. |
|
| Seute T, Leffers P, ten Velde GP, Twijnstra A Neurologic disorders in 432 consecutive patients with small cell lung carcinoma Cancer. 2004 Feb 15;100(4):801-6. |
|
| Soffietti R, Nobile M, Ruda R, Borgognone M, Costanza A,
Laguzzi E, Mutani R Second-line treatment with carboplatin for recurrent or progressive oligodendroglial tumors after PCV (procarbazine, lomustine, and vincristine) chemotherapy: a phase II study Cancer. 2004 Feb 15;100(4):807-13. |
|
|
van den Bent MJ Can chemotherapy replace radiotherapy in low-grade gliomas? Time for randomized studies Semin Oncol. 2003 Dec;30(6 Suppl 19):39-44. |
|
